ESMO 2022 Conference Coverage
ESMO 2022 on Advances in HER2-Targeted Therapy or Novel Targeted Therapies for HER2+ Esophagogastric Cancers
By
ESMO 2022 Conference Coverage
FEATURING
Kohei Shitara
By
ESMO 2022 Conference Coverage
FEATURING
Kohei Shitara
Login to view comments.
Click here to Login
GI